Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer’s Disease and Associated Sleep Disorders
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer’s Disease and Associated Sleep Disorders ; volume:84 ; number:11 ; day:4 ; month:10 ; year:2024 ; pages:1365-1378 ; date:11.2024
Drugs ; 84, Heft 11 (4.10.2024), 1365-1378, 11.2024
- Urheber
-
Carpi, Matteo
Mercuri, Nicola Biagio
Liguori, Claudio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40265-024-02096-3
- URN
-
urn:nbn:de:101:1-2502132105094.297646390068
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
17.06.2025, 07:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Carpi, Matteo
- Mercuri, Nicola Biagio
- Liguori, Claudio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators
Orexin A peptidergic system: comparative sleep behavior, morphology and population in brains between wild type and Alzheimer’s disease mice
5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Alzheimer’s disease: diagnostics, prognostics and the road to prevention
Multimodal Precision Prevention - A New Direction in Alzheimer’s Disease
Alzheimer’s disease prevention: from risk factors to early intervention
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold
The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators
Orexin A peptidergic system: comparative sleep behavior, morphology and population in brains between wild type and Alzheimer’s disease mice
5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Alzheimer’s disease: diagnostics, prognostics and the road to prevention
Multimodal Precision Prevention - A New Direction in Alzheimer’s Disease
Alzheimer’s disease prevention: from risk factors to early intervention
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold
The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators
Orexin A peptidergic system: comparative sleep behavior, morphology and population in brains between wild type and Alzheimer’s disease mice
5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Alzheimer’s disease: diagnostics, prognostics and the road to prevention
Multimodal Precision Prevention - A New Direction in Alzheimer’s Disease
Alzheimer’s disease prevention: from risk factors to early intervention
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold